Cecilia Ganslandt

Cecilia Ganslandt currently serves as VP of Clinical Development at Calluna Pharma since April 2025. Previously, Cecilia held the position of Global Medical Director at Vicore Pharma AB from April 2021 to March 2025. Cecilia has an extensive background in clinical development, having served as VP and Head of Clinical Development and Medical Affairs at Savara Pharmaceuticals from July 2016 to March 2021, and as Chief Medical Officer at Serendex Pharmaceuticals A/S from May 2014 to July 2016. Earlier roles include Medical Manager in Dermatology at AbbVie and Senior Medical Adviser at LEO Pharma, where Cecilia provided expertise in dermatology and was involved in global clinical development. Cecilia began a medical career as a physician at Karlskrona Hospital and Nybro Health Centre after earning an MD from Lund University and an MSc in Pharmaceutical Medicine from the University of Surrey.